Centessa Pharmaceuticals (CNTA) Exchange Rate Effect (2020 - 2026)
Centessa Pharmaceuticals (CNTA) reported Exchange Rate Effect of $182000.0 for Q1 2026, up 112.0% year-over-year from $85850.1 in Q1 2025, and down 89.19% quarter-over-quarter from $1.7 million in Q4 2025.
Centessa Pharmaceuticals (CNTA) Exchange Rate Effect (2020 - 2026) Analysis & Trends
Centessa Pharmaceuticals (CNTA) has 7 years of Exchange Rate Effect data on file, last reported at $182000.0 in Q1 2026.
- Exchange Rate Effect for Q1 2026 came in at $182000.0, up 112.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.3 million (up 345.78% YoY), and the FY2025 annual result was -$448000.0, down 136.51% from the prior year.
- Exchange Rate Effect retreated to $182000.0 in Q1 2026 per CNTA's latest filing, from $1.7 million in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $3.0 million in Q4 2024 and troughed at -$1.9 million in Q3 2024.
- A 5-year average of $68117.6 and a median of -$113000.0 in 2025 frame the typical range for Exchange Rate Effect.
- On a YoY basis, Exchange Rate Effect climbed as much as 701.59% in 2024 and fell as far as 965.45% in 2024.
- A 5-year view of Exchange Rate Effect shows it stood at $722000.0 in 2022, then plunged by 169.81% to -$504000.0 in 2023, then soared by 701.59% to $3.0 million in 2024, then sank by 44.49% to $1.7 million in 2025, then tumbled by 89.19% to $182000.0 in 2026.
- Business Quant data shows CNTA's Exchange Rate Effect at $182000.0 in Q1 2026, $1.7 million in Q4 2025, and -$501000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 8.68 Mn |
| 10 | Centessa Pharmaceuticals | 6.15 Bn | 6.15 Bn | - | 182,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 182,000.00 |
| Mar 31, 2026 | 182,000.00 |
| Dec 31, 2025 | 1.68 Mn |
| Dec 31, 2025 | 1.68 Mn |
| Sep 30, 2025 | -501,000.00 |
| Sep 30, 2025 | -501,000.00 |
| Jun 30, 2025 | -113,000.00 |
| Jun 30, 2025 | -113,000.00 |
| Mar 31, 2025 | -1.52 Mn |
| Mar 31, 2025 | -1.52 Mn |
| Dec 31, 2024 | 3.03 Mn |
| Dec 31, 2024 | 3.03 Mn |
| Sep 30, 2024 | -1.90 Mn |
| Sep 30, 2024 | -1.90 Mn |
| Jun 30, 2024 | -120,000.00 |
| Jun 30, 2024 | -120,000.00 |
| Mar 31, 2024 | 219,000.00 |
| Mar 31, 2024 | 219,000.00 |
| Dec 31, 2023 | -504,000.00 |
| Dec 31, 2023 | -504,000.00 |